Michael Douglas Taylor, President and CEO at Deciphera Pharmaceuticals, Inc. (DCPH), sold 1,700 shares at $28.01 ($48K) on 2019-02-05, disclosed to the SEC on 2019-02-07.
Scheduled sale ($48k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |